BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15738593)

  • 1. [Stage IV Wilms' tumour -- analysis of treatment results, according to the SIOP 93-01 protocol, at the Medical University of Gdańsk].
    Stefanowicz J; Sierota D; Połczyńska K; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):193-6. PubMed ID: 15738593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J; Sierota D; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal neoplasms in children].
    Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
    Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
    Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
    Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumour in Malawi: surgical staging to stratify postoperative chemotherapy?
    Borgstein E; Kamiza S; Vujanic G; Pidini D; Bailey S; Tomoka T; Banda K; Kaspers G; Molyneux E; Israels T
    Pediatr Blood Cancer; 2014 Dec; 61(12):2180-4. PubMed ID: 25213396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relapses in children with nephroblastoma--a single centre experience].
    Stefanowicz J; Sierota D; Połczyńska K; Adamkiewicz-Drozyńska E; Szołkiewicz A; Bień E; Stachowicz-Stencel T; Komasara L; Czauderna P; Balcerska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):523-30. PubMed ID: 16719165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late side-effects of treatment in patients with nephroblastoma].
    Sierota D; Stefanowicz J; Aleszewicz-Baranowska J; Birkholz D; Kosiak W; Adamkiewicz-Drozyńska E; Balcerska A
    Med Wieku Rozwoj; 2005; 9(3 Pt 2):517-22. PubMed ID: 16719164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of chemotherapy in treatment of nephroblastoma in children. Report of the Polish Pediatric Group re. treatments of solid tumors].
    Sawicz-Birkowska K; Czernik J; Godziński J; Bagłaj M; Balcerska A; Daszkiewicz P; Dembowska B; Drozyńska U; Kantorowicz S; Kazanowska B; Kaski K; Madziara W; Perek D; Skotnicka G; Rokicka-Milewska R; Radwańska U; Wysocki M; Apoznański W
    Pol Merkur Lekarski; 1998 Mar; 4(21):134-6. PubMed ID: 9640063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.
    de Kraker J; Graf N; van Tinteren H; Pein F; Sandstedt B; Godzinski J; Tournade MF;
    Lancet; 2004 Oct 2-8; 364(9441):1229-35. PubMed ID: 15464183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study].
    Ludwig R; Weirich A; Pötter R; Harms D; Bürger D; Michaelis J; Erttmann R; Weinel P; Haas RJ; Ritter J
    Klin Padiatr; 1992; 204(4):204-13. PubMed ID: 1325574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
    Sultan I; Masarweh M; Ismael T; Al-Hussaini M; Almousa A; Ali HM; Rodriguez-Galindo C; Ghandour K
    J Pediatr Hematol Oncol; 2009 May; 31(5):333-8. PubMed ID: 19415012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors in relapses of Wilms' tumor--results for the Polish Pediatric Solid Tumors Study Group.
    Niedzielska E; Bronowicki K; Pietras W; Sawicz-Birkowska K; Trybucka K; Rąpała M; Karpińska-Derda I; Kurylak A; Marciniak-Stępak P; Panasiuk A; Nurzyńska-Flak J; Peregud-Pogorzelski J; Pietrys D; Rurańska I; Sobol G; Stefanowicz J; Szymik-Kantorowicz S; Zubowska M; Godziński J
    Adv Clin Exp Med; 2014; 23(6):925-31. PubMed ID: 25618119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I; van Tinteren H; Bergeron C; de Kraker J;
    Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy.
    Maes P; Delemarre J; de Kraker J; Ninane J
    Eur J Cancer; 1999 Sep; 35(9):1356-60. PubMed ID: 10658527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bilateral Wilms' tumour. Results of treatment in 29 children].
    Sawicz-Birkowska K; Apoznanski W; Dembowska-Bagińska B; Balcerska A; Szymik-Kantorowicz S; Perek D; Wachowiak J; Wysocki M; Klepacka T; Zaleska-Dorobisz U
    Med Wieku Rozwoj; 2003; 7(3):369-80. PubMed ID: 14963344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.